Department of Clinical Sciences, College of Veterinary Medicine, North Carolina State University, Raleigh, North Carolina.
Department of Veterinary Clinical Sciences, The Ohio State University, Columbus, Ohio.
J Vet Intern Med. 2019 May;33(3):1127-1140. doi: 10.1111/jvim.15488. Epub 2019 Apr 11.
This report, issued by the ACVIM Specialty of Cardiology consensus panel, revises guidelines for the diagnosis and treatment of myxomatous mitral valve disease (MMVD, also known as endocardiosis and degenerative or chronic valvular heart disease) in dogs, originally published in 2009. Updates were made to diagnostic, as well as medical, surgical, and dietary treatment recommendations. The strength of these recommendations was based on both the quantity and quality of available evidence supporting diagnostic and therapeutic decisions. Management of MMVD before the onset of clinical signs of heart failure has changed substantially compared with the 2009 guidelines, and new strategies to diagnose and treat advanced heart failure and pulmonary hypertension are reviewed.
本报告由 ACVIM 心脏病学专业共识小组发布,修订了 2009 年发布的犬黏液瘤性二尖瓣疾病(MMVD,也称为心内膜炎和退行性或慢性瓣膜性心脏病)的诊断和治疗指南。对诊断以及医疗、手术和饮食治疗建议进行了更新。这些建议的强度基于支持诊断和治疗决策的可用证据的数量和质量。与 2009 年的指南相比,心力衰竭临床症状出现前的 MMVD 管理已发生重大变化,并且还审查了诊断和治疗晚期心力衰竭和肺动脉高压的新策略。